- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02099513
The Mobile Health Platform (mHealth)
The Mobile Health Platform - Development and Feasibility Evaluation
This study develops and pilots the initial interface of our mobile health platform that will allow for intra-individual tailoring and personalization of health interventions. This will allow for just-in-time interventions that adapt both the content and timing, not just initially, but also over time based upon prior outcome data, responses to an intervention, current environmental and social context, activity level, location, time, and an individual's psychophysiological state.1,2
Aim 1: To develop the initial interface of the mobile health platform that will allow patients to report and receive data representing multiple health domains including blood pressure, pO2 (pulse oximeter), values, weight, physical activity, calories burned, sleep, and self-report survey measures such as pain and fatigue.
Aim 2: To assess feasibility of the mobile health platform to receive and deliver data representing multiple health domains over 1 month through a single-case study design (N=6).3 Aim 3: To develop an algorithm using the diet data collected in Aim 1 that will facilitate adaptive work by providing patients with automated real time feedback on their progress.
Aim 4: To develop an algorithm using the diet data collected in Aim 1 that will that will facilitate adaptive approaches by alerting clinicians on the progress of their patients.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
At baseline we will collect demographic variables and acceptance and use of technology from surveys, and biological variables including blood pressure, weight, and blood glucose from electronic medical records. Over a period of 1 month, participants will be asked to track and collect daily data on weight using the iHealth wireless scale. Participants will also collect blood pressure (BP), pO2, and pulse using the iHealth blood pressure device. Physical activity and sleep activity will be measured using the fitbit device. Participants will receive evidence-based daily nutrition and exercise weight loss messages via text messages.
Following the one-month observation participants will be asked to complete a follow-up survey on acceptance and use of technology and to undergo a post-formative semi-structure telephone interview to discuss their perception of the usefulness and attitudes toward the platform, technical difficulties and barriers, and recommendations for future development.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University Medical Center, Pickens Primary Care Clinic
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patient of Picket primary care clinic
- All subjects will provide written informed consent.
- Three participants who have multiple chronic illnesses.
- Chronic illnesses of obesity (BMI>29)
- Chronic hypertension (SBP>140)
- Three healthy participants who do not have any chronic illnesses.
- Own a smartphone with a data and text messaging plan.
- Have Wifi available in the home.
Exclusion Criteria:
- No internet/Wifi available in the home.
- No Smartphone
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Enhedens gennemførlighed
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in the Acceptance and use of technology survey
Tidsramme: Baseline, up to 1 Month
|
Subject will take survey at Baseline, and the 1 month mark.
|
Baseline, up to 1 Month
|
|
Perception of perceived usefulness, attitudes, and experiences
Tidsramme: 1 month
|
Questions will be asked in the interviews regarding perceived usefulness, attitudes, and experiences of the mHealth applications.
The results will be divided into three main categories of positive, negative, and neutral perceptions.
|
1 month
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Ryan J. Shaw, RN, Phd, Duke University
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Pro00048816
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Forhøjet blodtryk
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien
-
University Hospital, BrestIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Frankrig
-
Shanghai Zhongshan HospitalIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
-
Rutgers, The State University of New JerseyRekrutteringPulmonal arteriel hypertension | Pulmonal hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension af medfødt hjertesygdom | Pulmonal arteriel hypertension forbundet med skistosomiasis (lidelse) | Pulmonal arteriel og kronisk tromboembolisk pulmonal... og andre forholdForenede Stater
Kliniske forsøg med The Mobile Health Platform
-
Sun Yat-sen UniversityAfsluttet
-
Emory UniversityNational Institute of Mental Health (NIMH); Georgia Institute of Technology og andre samarbejdspartnereAfsluttetHiv | Brug af mobiltelefon | Stigma, socialForenede Stater
-
Universidade Federal de Sao CarlosTufts Medical CenterAfsluttet
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Oncology Nursing Society; Villanova UniversityAfsluttetOverlevende af børnekræftForenede Stater
-
CUSH Health Ltd.University of SussexIkke rekrutterer endnuUtilsigtet fald
-
University of VictoriaAfsluttet
-
Johns Hopkins UniversityApple Inc.; iHealthAfsluttetMyokardieinfarkt | Koronararteriesygdom | Akut koronarsyndrom | Akut myokardieinfarktForenede Stater
-
M.A.G.I.C. Clinic LTDHanalytics Solutions Inc.RekrutteringMitokondrielle sygdomme | Fabrys sygdom | Metabolisk sygdom | Gauchers sygdom | Pompes sygdomCanada
-
University Hospital, Clermont-FerrandUkendt
-
Mayo ClinicAfsluttetRheumatoid arthritisForenede Stater